Bellicum Pharmaceuticals/ US0794814048 /
2023-06-01 10:00:00 PM | Chg. - | Volume | Bid1:48:25 AM | Ask12:22:23 AM | High | Low |
---|---|---|---|---|---|---|
0.6220USD | - | 284,009 Turnover: 166,331.7448 |
0.6100Bid Size: 100 | 0.6290Ask Size: 500 | 0.7000 | 0.6210 |
GlobeNewswire
01-08
NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Tran...
GlobeNewswire
2022-03-24
Bellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire
2022-01-26
Bellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology Conference
GlobeNewswire
2021-12-06
Bellicum Announces Positive Interim Data from Phase 1/2 GoCAR-T® Studies, Secures $35 Million Privat...
GlobeNewswire
2021-11-04
Bellicum Reports Third Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire
2021-09-03
Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Confere...
GlobeNewswire
2021-09-01
Cidara Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Financial Officer and Chief Business...
GlobeNewswire
2021-09-01
Bellicum and MD Anderson Announce Additional License Agreement for Use of CaspaCIDe® Safety Switch
GlobeNewswire
2021-08-12
Bellicum Reports Second Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire
2021-07-26
Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
2021-06-28
Bellicum Enters License Agreement with UNC Lineberger and Mass General for Use of CaspaCIDe® Safety ...
GlobeNewswire
2021-06-01
Invectys nominates Rosemary Williams, CPA, as Vice-President for Administration and Controller
GlobeNewswire
2021-05-17
Bellicum Reports First Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire
2021-03-30
Bellicum Reports Fourth Quarter 2020 Financial Results and Provides Operational Update
GlobeNewswire
2021-03-23
Bellicum to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
GlobeNewswire
2021-03-04
Bellicum Announces First Reported Use of CaspaCIDe® Safety Switch to Mitigate CAR-T Cell Toxicity
GlobeNewswire
2021-03-01
Corcept Therapeutics Expands Executive Team; Atabak Mokari Joins As Chief Financial Officer; Charles...
GlobeNewswire
2021-01-28
Bellicum Reports FDA Lifted Clinical Hold on BPX-601 Phase 1/2 Clinical Trial
GlobeNewswire
2020-11-05
Bellicum Reports Third Quarter 2020 Financial Results and Provides Operational Update